ABT vs BKNG · P/E 25, rev $44.33B vs P/E 36, rev $7.35B
Abbott Laboratories (ABT) versus Booking Holdings Inc (BKNG) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Booking Holdings Inc (BKNG) is a travel services company listed on US. It is led by Glenn D. Fogel.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported BKNG revenue for 2026-06-30 was $7.35B. Revenue was up 32.9% from 2026-03-31 to 2026-06-30. BKNG currently screens at market cap $186.03B and trailing P/E 35.6.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. BKNG currently screens at market cap $186.03B and trailing P/E 35.6.
Not investment advice. Open the ABT and BKNG stock pages for the full models.
Not investment advice.